Vitronectin and Brain Tumor Study

Vitronectin and Brain Tumor Study

08/14/23

Publication Title:

ABL1 and ABL2 Promote Medulloblastoma Leptomeningeal Dissemination 

 

Advanced BioMatrix Products Used: 

Vitronectin

 

How the products were used:

Vitronectin was used as a coating for culturing cells as part of a medulloblastoma leptomeningeal dissemination study. 

 

Article Conclusion:

Both pharmacologic inhibition of ABL1/2 and ABL1/2 knockdown resulted in decreased expression of c-MYC, identifying a putative signaling pathway, and genes/pathways related to oncogenesis and neurodevelopment were differentially expressed between ABL1/2 knockdown and control medulloblastoma cells. 

 

Link to the publication:

https://academic.oup.com/noa/advance-article/doi/10.1093/noajnl/vdad095/7238388 

 


Share Article: